News
Viking Therapeutics (VKTX 1.70%) is developing VK2735, a dual GLP-1/GIP receptor agonist for obesity treatment. The company ...
Pfizer Inc. (NYSE: PFE) ranks among the best set-it-and-forget-it stocks to buy. On June 26, Pfizer Inc. (NYSE:PFE) declared ...
The combination of climate change and pathogen expansion could be fueling a surge in infectious diseases. GEN consulted ...
Activist investor Starboard Value disclosed a 9% stake in Tripadvisor on Thursday and said the stock was undervalued. Shares ...
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...
On July 2, 2025, it was reported that Senator Ron L Wyden executed a sale of Pfizer PFE +0.24% Get Free Report stock, valued between $1,001 and $15,000. The transaction, recorded in the July filing, ...
The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...
Discover why options trading trends, robust R&D, and strong free cash flow position Pfizer Inc. for growth. Click for my ...
The Justice Department changed its policy on foreign corruption cases, which might have put an end to investigations into the ...
At recent prices, the yield you receive from Pfizer is more than four times the amount you'd receive from the average ...
Shares of Pfizer Inc. PFE rose 1.12% to $25.32 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.47% to 6,227.42 and the Dow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results